ReproCELL Incorporated 6RC.F Stock
ReproCELL Incorporated Price Chart
ReproCELL Incorporated 6RC.F Financial and Trading Overview
ReproCELL Incorporated stock price | 0.6 EUR |
Previous Close | 1.72 EUR |
Open | 1.76 EUR |
Bid | 1.76 EUR x 50000 |
Ask | 2.16 EUR x 10000 |
Day's Range | 1.76 - 1.76 EUR |
52 Week Range | 1.37 - 2.54 EUR |
Volume | 550 EUR |
Avg. Volume | 53 EUR |
Market Cap | 165.61M EUR |
Beta (5Y Monthly) | 0.648659 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
6RC.F Valuation Measures
Enterprise Value | -6228536832 EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.0560819 |
Price/Book (mrq) | 0.01972851 |
Enterprise Value/Revenue | -2.109 |
Enterprise Value/EBITDA | 20.223 |
Trading Information
ReproCELL Incorporated Stock Price History
Beta (5Y Monthly) | 0.648659 |
52-Week Change | 26.61% |
S&P500 52-Week Change | 20.43% |
52 Week High | 2.54 EUR |
52 Week Low | 1.37 EUR |
50-Day Moving Average | 1.7 EUR |
200-Day Moving Average | 1.78 EUR |
6RC.F Share Statistics
Avg. Volume (3 month) | 53 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 84.92M |
Float | 81.32M |
Short Ratio | N/A |
% Held by Insiders | 5.82% |
% Held by Institutions | 4.21% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | -10.32% |
Operating Margin (ttm) | -12.056% |
Gross Margin | 38.63% |
EBITDA Margin | -10.42% |
Management Effectiveness
Return on Assets (ttm) | -2.70% |
Return on Equity (ttm) | -4.11% |
Income Statement
Revenue (ttm) | 2.95B EUR |
Revenue Per Share (ttm) | 35.06 EUR |
Quarterly Revenue Growth (yoy) | -2.10% |
Gross Profit (ttm) | N/A |
EBITDA | -308000000 EUR |
Net Income Avi to Common (ttm) | -305000000 EUR |
Diluted EPS (ttm) | -0.02 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 6.38B EUR |
Total Cash Per Share (mrq) | 75.1 EUR |
Total Debt (mrq) | 0 EUR |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 9.589 |
Book Value Per Share (mrq) | 89.211 |
Cash Flow Statement
Operating Cash Flow (ttm) | -140000000 EUR |
Levered Free Cash Flow (ttm) | -399500000 EUR |
Profile of ReproCELL Incorporated
Country | Germany |
State | N/A |
City | Yokohama |
Address | MetLife Shin-Yokohama Building |
ZIP | 222-0033 |
Phone | N/A |
Website | https://www.reprocell.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
ReproCELL Incorporated provides stem cell research services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, pluripotent stem cell culture media, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, and synfire induced neurons; 3D cell culture; and labware. The company also provides genomics, clinical stem cell research, preclinical drug discovery CRO, human tissue samples, clinical laboratory, diagnostic, and gene editing services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.
Q&A For ReproCELL Incorporated Stock
What is a current 6RC.F stock price?
ReproCELL Incorporated 6RC.F stock price today per share is 0.6 EUR.
How to purchase ReproCELL Incorporated stock?
You can buy 6RC.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ReproCELL Incorporated?
The stock symbol or ticker of ReproCELL Incorporated is 6RC.F.
Which industry does the ReproCELL Incorporated company belong to?
The ReproCELL Incorporated industry is Biotechnology.
How many shares does ReproCELL Incorporated have in circulation?
The max supply of ReproCELL Incorporated shares is 113.65M.
What is ReproCELL Incorporated Price to Earnings Ratio (PE Ratio)?
ReproCELL Incorporated PE Ratio is now.
What was ReproCELL Incorporated earnings per share over the trailing 12 months (TTM)?
ReproCELL Incorporated EPS is 0 EUR over the trailing 12 months.
Which sector does the ReproCELL Incorporated company belong to?
The ReproCELL Incorporated sector is Healthcare.